美国 · SEC FORM 4
Ceribell, Inc.
CBLL · Nasdaq · CIK 0001861107 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
76 同一窗口内观察到的 Form 4 交易行
41 sales · 35 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 8 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-10-15 · BONDERMAN DAVID; COULTER JAMES G; TPG GP A, LLC; WINKELRIED JON.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 2,017,836
- 上期报告
- 1,818,916
- 日均成交量
- 400,380
- 回补天数
- 5.0
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
192 transaction lines in the latest 365-day window; 255 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Woo Raymond | 卖出 (S) | Common Stock | 4,887 | USD 24.38 | USD 119,145 | SEC 申报 ↗ |
| 2026-10-01 | Woo Raymond | 期权行权/转换 (M) | Common Stock | 4,887 | USD 3.65 | USD 17,862 | SEC 申报 ↗ |
| 2026-09-15 | Chao Xingjuan | 卖出 (S) | Common Stock | 20,846 | USD 25.03 | USD 521,775 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Woo Raymond | 卖出 (S) | Common Stock | 4,887 | USD 24.38 | USD 119,145 | SEC 申报 ↗ |
| 2026-10-01 | Woo Raymond | 期权行权/转换 (M) | Common Stock | 4,887 | USD 3.65 | USD 17,862 | SEC 申报 ↗ |
| 2026-09-15 | Chao Xingjuan | 卖出 (S) | Common Stock | 20,846 | USD 25.03 | USD 521,775 | SEC 申报 ↗ |
| 2026-09-15 | Blumberg Scott | 卖出 (S) | Common Stock | 846 | USD 25.00 | USD 21,150 | SEC 申报 ↗ |
| 2026-09-15 | Blumberg Scott | 期权行权/转换 (M) | Common Stock | 846 | USD 9.41 | USD 7,961 | SEC 申报 ↗ |
| 2026-09-08 | Woo Raymond | 卖出 (S) | Common Stock | 4,887 | USD 24.33 | USD 118,901 | SEC 申报 ↗ |
| 2026-09-08 | Woo Raymond | 期权行权/转换 (M) | Common Stock | 13,276 | USD 2.76 | USD 36,653 | SEC 申报 ↗ |
| 2026-09-08 | Foehr David | 卖出 (S) | Common Stock | 9,255 | USD 24.25 | USD 224,451 | SEC 申报 ↗ |
| 2026-09-08 | Foehr David | 期权行权/转换 (M) | Common Stock | 7,500 | USD 4.70 | USD 35,250 | SEC 申报 ↗ |
| 2026-09-02 | Chao Xingjuan | 卖出 (S) | Common Stock | 39,540 | USD 24.61 | USD 973,079 | SEC 申报 ↗ |
| 2026-09-02 | Chao Xingjuan | 期权行权/转换 (M) | Common Stock | 25,000 | USD 4.70 | USD 117,500 | SEC 申报 ↗ |
| 2026-09-02 | Blumberg Scott | 卖出 (S) | Common Stock | 652 | USD 25.00 | USD 16,300 | SEC 申报 ↗ |
| 2026-09-02 | Blumberg Scott | 期权行权/转换 (M) | Common Stock | 652 | USD 9.41 | USD 6,135 | SEC 申报 ↗ |
| 2026-08-24 | Foehr David | 卖出 (S) | Common Stock | 859 | USD 23.95 | USD 20,573 | SEC 申报 ↗ |
| 2026-08-21 | Woo Raymond | 卖出 (S) | Common Stock | 1,979 | USD 24.02 | USD 47,536 | SEC 申报 ↗ |
| 2026-08-21 | Manni Joseph S. | 卖出 (S) | Common Stock | 1,361 | USD 24.02 | USD 32,691 | SEC 申报 ↗ |
| 2026-08-21 | Foehr David | 卖出 (S) | Common Stock | 993 | USD 24.02 | USD 23,852 | SEC 申报 ↗ |
| 2026-08-21 | Chao Xingjuan | 卖出 (S) | Common Stock | 6,068 | USD 24.02 | USD 145,753 | SEC 申报 ↗ |
| 2026-08-21 | Blumberg Scott | 卖出 (S) | Common Stock | 1,521 | USD 24.02 | USD 36,534 | SEC 申报 ↗ |
| 2026-08-19 | Chao Xingjuan | 卖出 (S) | Common Stock | 31,415 | USD 25.03 | USD 786,317 | SEC 申报 ↗ |
| 2026-08-19 | Blumberg Scott | 卖出 (S) | Common Stock | 33,512 | USD 25.03 | USD 838,805 | SEC 申报 ↗ |
| 2026-08-19 | Blumberg Scott | 期权行权/转换 (M) | Common Stock | 33,512 | USD 8.54 | USD 286,245 | SEC 申报 ↗ |
| 2026-08-18 | Chao Xingjuan | 卖出 (S) | Common Stock | 2,199 | USD 25.00 | USD 54,975 | SEC 申报 ↗ |
| 2026-08-18 | Blumberg Scott | 卖出 (S) | Common Stock | 990 | USD 25.00 | USD 24,750 | SEC 申报 ↗ |
| 2026-08-18 | Blumberg Scott | 期权行权/转换 (M) | Common Stock | 990 | USD 6.13 | USD 6,066 | SEC 申报 ↗ |
| 2026-08-13 | Chao Xingjuan | 期权行权/转换 (M) | Common Stock | 33,096 | USD 3.31 | USD 109,385 | SEC 申报 ↗ |
| 2026-08-13 | Taylor Joseph Michael | 卖出 (S) | Common Stock | 13,095 | USD 23.40 | USD 306,423 | SEC 申报 ↗ |
| 2026-08-03 | Chao Xingjuan | 卖出 (S) | Common Stock | 39,000 | USD 18.32 | USD 714,480 | SEC 申报 ↗ |
| 2026-08-03 | Chao Xingjuan | 期权行权/转换 (M) | Common Stock | 25,000 | USD 4.70 | USD 117,500 | SEC 申报 ↗ |
| 2026-07-28 | West Thomas A. | 奖励/授予 (A) | Common Stock | 16,011 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CBLL |
| CIK | 0001861107 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3845 Electromedical & Electrotherapeutic Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 255 transaction lines from 2024-10-11 to 2026-10-01 2 P purchase lines · 116 S sale lines · 137 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.